Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a single dose of RABI-767 for safety and efficacy in acute pancreatitis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• RABI-767

Snippet

Sponsor: Panafina, Inc. | Conditions: Acute Pancreatitis | Phase 2 | Status: RECRUITING